Gain- and loss-of-function studies in human Simpson–Golabi–Behmel syndrome (SGBS) adipocytes resulted in the identification of natriuretic peptide receptor 3 (NPR3) as target gene of miR-146a and as regulator of adipocyte insulin sensitivity. This evidence concerns the gene NPR3 and Simpson-Golabi-Behmel syndrome.